To test whether the Wnt3a‐induced decrease in membrane DAG and ceramide levels is associated with caveolae‐mediated endocytosis, we examined caveolin‐1 levels in HCC cells treated with either lipids or lipid inhibitors. The gene discussed is WNT3A; the disease is hepatocellular carcinoma.